{"id":403225,"date":"2020-12-18T22:53:25","date_gmt":"2020-12-19T03:53:25","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=403225"},"modified":"2020-12-18T22:53:25","modified_gmt":"2020-12-19T03:53:25","slug":"karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/","title":{"rendered":"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. &#8211; KPTI"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p>\nKARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. &#8211; KPTI\n<\/p>\n<p>NEW ORLEANS&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nFormer Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick &amp; Foti, LLC (\u201cKSF\u201d), announces that KSF has commenced an investigation into Karyopharm Therapeutics Inc. (NasdaqGS: KPTI).\n<\/p>\n<p>\nOn February 22, 2019, the Federal Drug Administration (&#8220;FDA&#8221;) reported serious flaws in the New Drug Application and the underlying clinical trial data for the Company\u2019s drug, selinexor. Specifically, the FDA detailed that the Company\u2019s clinical trials demonstrated a history of toxicity and limited efficacy findings due to its trial designs and faulted the Company for violating pre-specified trial protocols and guidance when attempting to use \u201creal-world\u201d data observations to bolster its case for approval.\n<\/p>\n<p>\nThereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws, which remains ongoing.\n<\/p>\n<p>\nKSF\u2019s investigation is focusing on whether Karyopharm\u2019s officers and\/or directors breached their fiduciary duties to Karyopharm\u2019s shareholders or otherwise violated state or federal laws.\n<\/p>\n<p>\nIf you have information that would assist KSF in its investigation, or have been a long-term holder of Karyopharm shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (<a rel=\"nofollow\" href=\"mailto:lewis.kahn@ksfcounsel.com\">lewis.kahn@ksfcounsel.com<\/a>), or visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqgs-kpti%2F&amp;esheet=52351614&amp;newsitemid=20201218005742&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqgs-kpti%2F&amp;index=1&amp;md5=43a96bf150f08eedb8127113dc2faaa4\">https:\/\/www.ksfcounsel.com\/cases\/nasdaqgs-kpti\/<\/a> to learn more.\n<\/p>\n<p>\nAbout Kahn Swick &amp; Foti, LLC\n<\/p>\n<p>\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\u2019s premier boutique securities litigation law firms. KSF serves a variety of clients \u2013 including public institutional investors, hedge funds, money managers and retail investors \u2013 in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.\n<\/p>\n<p>\nTo learn more about KSF, you may visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ksfcounsel.com&amp;esheet=52351614&amp;newsitemid=20201218005742&amp;lan=en-US&amp;anchor=www.ksfcounsel.com&amp;index=2&amp;md5=f9900eebbb8537cf2eb42dc83ffd836a\">www.ksfcounsel.com<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201218005742r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201218005742\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201218005742\/en\/<\/a><\/span><\/p>\n<p>\nKahn Swick &amp; Foti, LLC<br \/>\n<br \/>Lewis Kahn, Managing Partner<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:lewis.kahn@ksfcounsel.com\">lewis.kahn@ksfcounsel.com<br \/>\n<\/a><br \/>1-877-515-1850\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America Louisiana<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201218005742\/en\/752156\/3\/logo-square-pr.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. &#8211; KPTI NEW ORLEANS&#8211;(BUSINESS WIRE)&#8211; Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick &amp; Foti, LLC (\u201cKSF\u201d), announces that KSF has commenced an investigation into Karyopharm Therapeutics Inc. (NasdaqGS: KPTI). On February 22, 2019, the Federal Drug Administration (&#8220;FDA&#8221;) reported serious flaws in the New Drug Application and the underlying clinical trial data for the Company\u2019s drug, selinexor. Specifically, the FDA detailed that the Company\u2019s clinical trials demonstrated a history of toxicity and limited efficacy findings due to its trial designs and faulted the Company for violating &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. &#8211; KPTI&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-403225","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. - KPTI - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. - KPTI - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. &#8211; KPTI NEW ORLEANS&#8211;(BUSINESS WIRE)&#8211; Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick &amp; Foti, LLC (\u201cKSF\u201d), announces that KSF has commenced an investigation into Karyopharm Therapeutics Inc. (NasdaqGS: KPTI). On February 22, 2019, the Federal Drug Administration (&#8220;FDA&#8221;) reported serious flaws in the New Drug Application and the underlying clinical trial data for the Company\u2019s drug, selinexor. Specifically, the FDA detailed that the Company\u2019s clinical trials demonstrated a history of toxicity and limited efficacy findings due to its trial designs and faulted the Company for violating &hellip; Continue reading &quot;KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. &#8211; KPTI&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-19T03:53:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201218005742r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. &#8211; KPTI\",\"datePublished\":\"2020-12-19T03:53:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\\\/\"},\"wordCount\":416,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201218005742r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\\\/\",\"name\":\"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. - KPTI - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201218005742r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-12-19T03:53:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201218005742r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201218005742r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. &#8211; KPTI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. - KPTI - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/","og_locale":"en_US","og_type":"article","og_title":"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. - KPTI - Market Newsdesk","og_description":"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. &#8211; KPTI NEW ORLEANS&#8211;(BUSINESS WIRE)&#8211; Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick &amp; Foti, LLC (\u201cKSF\u201d), announces that KSF has commenced an investigation into Karyopharm Therapeutics Inc. (NasdaqGS: KPTI). On February 22, 2019, the Federal Drug Administration (&#8220;FDA&#8221;) reported serious flaws in the New Drug Application and the underlying clinical trial data for the Company\u2019s drug, selinexor. Specifically, the FDA detailed that the Company\u2019s clinical trials demonstrated a history of toxicity and limited efficacy findings due to its trial designs and faulted the Company for violating &hellip; Continue reading \"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. &#8211; KPTI\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-19T03:53:25+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201218005742r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. &#8211; KPTI","datePublished":"2020-12-19T03:53:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/"},"wordCount":416,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201218005742r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/","name":"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. - KPTI - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201218005742r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-12-19T03:53:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201218005742r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201218005742r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/karyopharm-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc-kpti\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. &#8211; KPTI"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=403225"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403225\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=403225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=403225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=403225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}